Telix Pharmaceuticals has introduced a new positron emission tomography (PET) radiochemistry solution, AlFluor.

PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

ClearNote Health has commenced subject enrolment in a multicentre, prospective study involving its Avantect pancreatic cancer ...

Grail has reported encouraging top-line performance and safety outcomes from its registrational PATHFINDER 2 study’s ...

Visby Medical has secured around $55m in its funding round to expedite the launch and distribution of its at-home Women's ...